McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study

by McKesson Ventures | Jun 4, 2019 | Portfolio News

GRAIL, a healthcare company focused on the early detection of cancer, today announced new data from its Circulating Cell-free Genome Atlas (CCGA) study that demonstrates the ability of GRAIL’s technology to detect cancer early with a single blood test. The data...

GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation

by McKesson Ventures | May 13, 2019 | Portfolio News

Liquid biopsy company GRAIL announced today that its multi-cancer test has been granted Breakthrough Device designation from the U.S. Food and Drug Administration. This investigational blood test is in development for the early detection of multiple cancer types in...

Trident Medical Center Joins Sarah Cannon Research Institute in National Early Cancer Detection Study

by McKesson Ventures | Sep 27, 2018 | Portfolio News

Trident Medical Center of Charleston, South Carolina, announced that it and Sarah Cannon, the Cancer Institute of HCA Healthcare, will participate in a study called STRIVE, which focuses on developing a test for early cancer detection. The STRIVE study is designed to...

GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors

by McKesson Ventures | Aug 10, 2018 | Portfolio News

GRAIL Inc. recently announced the appointment of Hal Barron, M.D., and Hans Bishop to its Board of Directors. Hal Barron is globally recognized for his clinical and scientific leadership. Currently he is the Chief Scientific Officer and President of R&D at...

GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products

by McKesson Ventures | Jul 12, 2018 | Portfolio News

GRAIL, a company whose mission is to detect cancer early, when it can be cured, recently announced the appointment of several key leaders as it continues to build its executive team. George Golumbeski has been appointed as President and will also serve on GRAIL’s...
Page 5 of 10« First«...34567...10...»Last »

Recent Posts

  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
McKesson Ventures
One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

Emerging Leaders 2024: Carrie Williams, McKesson Ventures

Forbes’ 2024 List of America’s Best Startup Employers

Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements

Komodo Health Unveils New Annual Report Illuminating the State of Data Mining in Life Sciences

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow